| VIRX Stock | | | USD 0.15 0.01 6.25% |
Viracta Therapeutics financial indicator trend analysis is much more than just breaking down Viracta Therapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Viracta Therapeutics is a good investment. Please check the relationship between Viracta Therapeutics Total Assets and its Net Tangible Assets accounts. Check out
World Market Map to better understand how to build diversified portfolios, which includes a position in Viracta Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in metropolitan statistical area.
For more information on how to buy Viracta Stock please use our
How to Invest in Viracta Therapeutics guide.
Total Assets vs Net Tangible Assets
Total Assets vs Net Tangible Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Viracta Therapeutics Total Assets account and
Net Tangible Assets. At this time, the significance of the direction appears to have strong relationship.
The correlation between Viracta Therapeutics' Total Assets and Net Tangible Assets is 0.69. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Net Tangible Assets in the same time period over historical financial statements of Viracta Therapeutics, assuming nothing else is changed. The correlation between historical values of Viracta Therapeutics' Total Assets and Net Tangible Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of Viracta Therapeutics are associated (or correlated) with its Net Tangible Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Tangible Assets has no effect on the direction of Total Assets i.e., Viracta Therapeutics' Total Assets and Net Tangible Assets go up and down completely randomly.
Correlation Coefficient | 0.69 |
| Relationship Direction | Positive |
| Relationship Strength | Significant |
Total Assets
Total assets refers to the total amount of Viracta Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Viracta Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.
Net Tangible Assets
The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.
Most indicators from Viracta Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Viracta Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
World Market Map to better understand how to build diversified portfolios, which includes a position in Viracta Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in metropolitan statistical area.
For more information on how to buy Viracta Stock please use our
How to Invest in Viracta Therapeutics guide.
Sales General And Administrative To Revenue is likely to rise to 53.81 in 2024, whereas
Selling General Administrative is likely to drop slightly above 13.7
M in 2024.
Viracta Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Viracta Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Viracta Therapeutics fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Viracta Stock Analysis
When running Viracta Therapeutics' price analysis, check to
measure Viracta Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Viracta Therapeutics is operating at the current time. Most of Viracta Therapeutics' value examination focuses on studying past and present price action to
predict the probability of Viracta Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Viracta Therapeutics' price. Additionally, you may evaluate how the addition of Viracta Therapeutics to your portfolios can decrease your overall portfolio volatility.